Weekly Recap | Alnylam Pharma -3.67%, consensus target above spotWeekly Review·40 minutes agoALNY-2.42%
Weekly Recap | Roivant Sciences +16.86%, closing in on record highsWeekly Review·Sep 12 at 06:42 AMROIV-0.53%
Weekly Recap | SPDR S&P Biotech -4.65%, most brokers rate it buyWeekly Review·Sep 12 at 05:07 AMXBI-0.97%LABD+3.09%
Weekly Recap | SPDR S&P Biotech +0.88%, constituent names hit 52-week highsWeekly Review·Sep 5 at 04:31 AMXBI-0.97%
Weekly Recap | SPDR S&P Biotech -2.02%, sector split as FDA win lifts select namesWeekly Review·Aug 29 at 04:01 AMXBI-0.97%
Weekly Recap | SPDR S&P Biotech +5.29%, AI and cancer vaccine catalysts fire up rallyWeekly Review·Aug 22 at 06:32 AMXBI-0.97%
